已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Evaluation of the Efficacy of Sacubitril/Valsartan on Radiofrequency Ablation in Patients with Hypertension and Persistent Atrial Fibrillation

医学 心房颤动 心脏病学 内科学 缬沙坦 血压 心力衰竭 射血分数 射频消融术 烧蚀
作者
Xiaobiao Zang,Zhihan Zhao,Ke Chen,Weifeng Song,Jifang Ma,You Zhou,Erpeng Liang,Haixia Fu,Wei Wang,Yonghui Zhao,Rongfeng Zhang
出处
期刊:Cardiovascular Drugs and Therapy [Springer Science+Business Media]
被引量:3
标识
DOI:10.1007/s10557-023-07493-6
摘要

To evaluate whether the effect of radiofrequency ablation can be improved by using sacubitril/valsartan (S/V) to control blood pressure in hypertensive patients with persistent atrial fibrillation.A total of 63 and 67 hypertension patients with persistent atrial fibrillation were enrolled in an S/V group and ACEI/ARB group, respectively. All patients underwent radiofrequency catheter ablation (RFCA). The blood pressure of the two groups was controlled within the range of 100-140 mmHg (high pressure) and 60-90 mmHg (low pressure). The clinical outcomes of the two groups were observed after 12 months of follow-up.No significant differences in blood pressure were observed between the S/V and ACEI/ARB groups. In addition, the recurrence rate of atrial fibrillation between the two groups was not different. The left atrial diameter was an independent predictor of recurrence (HR = 1.063, P = 0.008). However, in the heart failure subgroup, the recurrence rate of S/V was significantly lower than that of the ACEI/ARB group (P = 0.005), and Cox regression analysis showed that the recurrence risk of atrial fibrillation of the S/V group was 0.302 lower than that of the ACEI/ARB group. NT-proBNP, LVEF, and LAD were significantly improved in hypertension patients with heart failure when comparing cases before and at the end of follow-up.S/V is better than ACEI/ARB in reducing the recurrence of persistent atrial fibrillation in patients with hypertension and heart failure after RFCA.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
Smiling应助文茵采纳,获得10
3秒前
星辰大海应助饭ff采纳,获得10
3秒前
5秒前
wab完成签到,获得积分0
5秒前
酷波er应助雪白的夏山采纳,获得10
7秒前
leezh完成签到,获得积分10
8秒前
Trtr7985发布了新的文献求助10
9秒前
慕青应助漂亮白枫采纳,获得10
10秒前
华仔应助VIAI采纳,获得10
15秒前
15秒前
18秒前
笑而不语完成签到 ,获得积分10
18秒前
辛苦科研人完成签到 ,获得积分10
19秒前
20秒前
24秒前
恋雅颖月应助称心的思卉采纳,获得10
25秒前
yinjw发布了新的文献求助30
25秒前
WuYiHHH发布了新的文献求助10
25秒前
活泼的面包完成签到 ,获得积分10
29秒前
loong发布了新的文献求助10
30秒前
31秒前
orixero应助1234采纳,获得10
35秒前
35秒前
希望天下0贩的0应助loong采纳,获得10
35秒前
zsw发布了新的文献求助10
40秒前
44秒前
46秒前
47秒前
ding应助Iris采纳,获得10
51秒前
难过大神发布了新的文献求助10
52秒前
吃醋的喵酱完成签到,获得积分10
55秒前
55秒前
56秒前
赘婿应助hyhyhyhy采纳,获得10
58秒前
腼腆的修杰完成签到 ,获得积分10
58秒前
潘善若发布了新的文献求助10
59秒前
一直向前发布了新的文献求助10
1分钟前
honeylaker发布了新的文献求助10
1分钟前
bkagyin应助zsw采纳,获得10
1分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
Aktuelle Entwicklungen in der linguistischen Forschung 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989868
求助须知:如何正确求助?哪些是违规求助? 3531994
关于积分的说明 11255752
捐赠科研通 3270793
什么是DOI,文献DOI怎么找? 1805053
邀请新用户注册赠送积分活动 882215
科研通“疑难数据库(出版商)”最低求助积分说明 809208